Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 9401
TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464030BDBM464030(WX013 | US10787435, Example 013)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464027BDBM464027(WX011 | US10787435, Example 011)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464019BDBM464019(WX008 | US10787435, Example 008)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464021BDBM464021(WX009 | US10787435, Example 009)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464016BDBM464016(WX006 | US10787435, Example 006)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464017BDBM464017(WX007 | US10787435, Example 007)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464011BDBM464011(WX004 | US10787435, Example 004)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464015BDBM464015(WX005 | US10787435, Example 005)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 463999BDBM463999(WX002 | US10787435, Example 002 | US11117891, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464009BDBM464009(WX003 | US10787435, Example 003)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 463987BDBM463987(WX001 | US10787435, Example 001)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464053BDBM464053(WX030 | US10787435, Example 031)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464054BDBM464054(WX031 | US10787435, Example 032)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464044BDBM464044(US10787435, Example 030 | WX021 | US10787435, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464049BDBM464049(WX026 | US10787435, Example 026)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464047BDBM464047(WX024 | US10787435, Example 024)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464048BDBM464048(WX025 | US10787435, Example 025)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464045BDBM464045(WX022 | US10787435, Example 022)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464046BDBM464046(WX023 | US10787435, Example 023)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464044BDBM464044(US10787435, Example 030 | WX021 | US10787435, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464040BDBM464040(WX018 | US10787435, Example 018)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464042BDBM464042(WX019 | US10787435, Example 019)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464069BDBM464069(WX046 | US10787435, Example 047)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464067BDBM464067(WX044 | US10787435, Example 045)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464068BDBM464068(WX045 | US10787435, Example 046)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464066BDBM464066(WX043 | US10787435, Example 044)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464063BDBM464063(WX040 | US10787435, Example 041)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464061BDBM464061(WX038 | US10787435, Example 039)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464062BDBM464062(WX039 | US10787435, Example 040)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464059BDBM464059(WX036 | US10787435, Example 038)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464060BDBM464060(WX037 | US10787435, Example 037)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464057BDBM464057(WX034 | US10787435, Example 035)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464058BDBM464058(WX035 | US10787435, Example 036)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464055BDBM464055(WX032 | US10787435, Example 033)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464056BDBM464056(WX033 | US10787435, Example 034)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464079BDBM464079(WX056 | US10787435, Example 057)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464080BDBM464080(WX057 | US10787435, Example 058)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464077BDBM464077(WX054 | US10787435, Example 055)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464078BDBM464078(WX055 | US10787435, Example 056)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464075BDBM464075(WX052 | US10787435, Example 053)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464076BDBM464076(WX053 | US10787435, Example 054)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464073BDBM464073(WX050 | US10787435, Example 051)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464074BDBM464074(WX051 | US10787435, Example 052)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464072BDBM464072(WX049 | US10787435, Example 050)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464031BDBM464031(WX014 | US10787435, Example 014)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464070BDBM464070(WX047 | US10787435, Example 048)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464024BDBM464024(WX010 | US10787435, Example 010)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464050BDBM464050(WX027 | US10787435, Example 028)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464036BDBM464036(WX016 | US10787435, Example 016)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 464071BDBM464071(WX048 | US10787435, Example 049)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: